300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Recruiting
Beauty
Fashion
Climate
LGBT
Web3
Cannabis
Celebrity
Medical
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Theatre
Music
Manufacturing
Art
Real Estate
Sporting Goods
Social Media
FinTech
Financial Services
Franchise
Non Profit
Internet
Finance
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Digital Media
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Gibraltar
Burkina Faso
Africa
Singapore
Brazil
LATAM
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Bangladesh
Barbados
Belgium
Europe
Jordan
Qatar
Ethiopia
Austria
Angola
Azerbaijan
Cyprus
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Belarus
Lebanon
Finland
Mongolia
Peru
Slovenia
San Marino
Chile
Ukraine
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Zhongqi Capital, VC Fund

Zhongqi Capital

VC Fund

Beijing, China

Zhongqi Capital is an investment firm that offers a private equity investment management platform.

Total investments:
21
Last investment:
Lead investor:
48%

Last updated:

Industries Zhongqi Capital invests in

ManufacturingBiotechnologyAdvanced MaterialsIndustrialElectronics

Stages Zhongqi Capital invests in

Series ASeedSeries BSeries DPrivate Equity

Countries Zhongqi Capital invests in

China

Round sizes

Series A $35M–$59M

Round size

Series A
$35M–$59M

Investment Focus

Industry

  • Manufacturing 7 (33%)
  • Biotechnology 5 (24%)
  • Advanced Materials 5 (24%)
  • Industrial 4 (19%)
  • Electronics 4 (19%)
See all 24 industries →

Stage

  • Series A 8 (38%)
  • Seed 5 (24%)
  • Series B 2 (10%)
  • Series D 2 (10%)
  • Private Equity 2 (10%)
See all 7 stages →

Investments

CompanyDescriptionRoundLinks
Langsilicon Technology is an electronic component R&D firm that specializes in the design, development, and sales of silicon-based passive components (capacitors, inductors, and resistors). $29.9M / Seed / Sep 23, 2026
Inno Pharmaceutical Technology specializes in research on the pathogenesis of atherosclerosis. The company focuses on the development of targeted nanoliposomes, targeting molecules with independent intellectual property rights, and currently focuses on the plaque reversal treatment of atherosclerosis. $119.2M / Series D / Sep 09, 2026
SiranBio is a biotechnology that develops innovative siRNA drugs. $59.5M / Series A / Aug 20, 2026
Weikai High-Tech
Sifang Weikai High-Tech operates an intelligent Industry 4.0 production base, and its products are widely used in autos, motorbikes, rail transit, and construction machines. Series A / Aug 03, 2026
Sifang Weikai
Sifang Weikai focuses on high-end industrial decorative coatings and functional materials for high-end equipment. Series A / Aug 02, 2026
Topwell Biotech Topwell Biotech
Topwell Biotech is a biotechnology company offering research and development of synthetic biology technologies and biodegradable materials. Series A / May 21, 2026
Chengdu New Radiomedicine Technology Co.,Ltd. is a Chinese medical isotopes provider. Our business covers research, manufacture and sales for medical isotopes and products. We provide services for malignant tumor diagnosis and treatments and radionuclides medicine technology support and consulting.In April 2016, the company was founded bythree co-founders experienced in radionuclides research and development. Jihui Qian, former President of Nuclear Power Institute of China (NPIC), former Deputy Director-General of International Atomic Energy Agency (IAEA); Maoliang Li, former Director of Chengdu Isotopes Institute of NPIC; and Jiming Cai, former Vice President of Sichuan Institute of Atomic Energy.The company is located in Western Airport Development District, Shuangliu, Chengdu, with an area of 71 Are, registered capital of 32.83 million CNY, and total investment of 300 million CNY. The project is listed as "Annual Key Investment Projects of Sichuan Province and Chengdu City in 2017, 2018 and 2019". At present, the company has over 80 employees, with more than 60 R&D specialists, including 1 academician of Chinese Academy of Engineering, 2 experts of Thousand Talent Project, 2 academic and technical leaders from Sichuan province, 10 researchers (associate researchers), and more than 20 people with middle or senior titles. Among them, there are 6 PhDs and over 30 graduates. The proportion of R&D staff has reached 70%, making CNRT the most innovative technology enterprise in the radiopharmaceutical industry in China. $145.4M / Series E / Apr 03, 2026
Yonggeng Technology
Yonggeng Technology focuses on the development and industrial application of high-end photolithography media materials. Series A / Nov 04, 2025
Feature-Tec is a filtration and separation technology that specializes in R&D, design, manufacturing, and verification. Private Equity / Nov 03, 2025
NEWCCESS specializes in PCB drilling entry and backup boards and electronic new materials. It was incorporated in 1996, and its products have been exported to countries and regions, such as the U.S., Europe, Japan, South Korea, Southeast Asia, Taiwan, and more. For over 20 years, Newccess has been strategically positioned in major PCB marketslocated throughout China. Three subsidiaries were created, which are Kunshan Newccess Electronic Co., Ltd., Hunan Newccess Electronic New Materials Co., Ltd., and Yantai Newccess New Materials Co., Ltd. Seed / Oct 21, 2025
See all 21 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Recruiting
Beauty
Fashion
Climate
LGBT
Web3
Cannabis
Celebrity
Medical
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Theatre
Music
Manufacturing
Art
Real Estate
Sporting Goods
Social Media
FinTech
Financial Services
Franchise
Non Profit
Internet
Finance
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Digital Media
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Gibraltar
Burkina Faso
Africa
Singapore
Brazil
LATAM
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Bangladesh
Barbados
Belgium
Europe
Jordan
Qatar
Ethiopia
Austria
Angola
Azerbaijan
Cyprus
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Belarus
Lebanon
Finland
Mongolia
Peru
Slovenia
San Marino
Chile
Ukraine
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Zhongqi Capital invest in?

Zhongqi Capital invests primarily in Manufacturing, Biotechnology and Advanced Materials startups, most often at Series A and Seed stage. Most of the 21 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Zhongqi Capital invest in?

Zhongqi Capital typically joins rounds of $35M–$59M at Series A. These are whole funding-round sizes, not Zhongqi Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Zhongqi Capital took part in.

When did Zhongqi Capital last invest?

The most recent investment recorded for Zhongqi Capital closed in Sep 2026. Shizune tracks 21 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Zhongqi Capital Zhongqi Capital Find emails